Tags : Dr. Reddy’s

M&A

Dr. Reddy’s to Acquire Wockhardt’s Select Business Divisions for ~$259M

Shots: Dr. Reddy’s acquires Wockhardt’s select divisions of its branded generics business in India and other international territories of Nepal, Sri Lanka, Bhutan and Maldives for ~$259M (Rs.1850 crores) The focus of the acquisition is to boost Dr. Reddy’s presence in the high growth therapy areas with the addition of Wockhardt’s Practin, Zedex, Bro-zedex, Tryptomer […]Read More

Pharma

Dr. Reddy’s to Acquire a Portfolio of 42 Abbreviated New

Shots: Dr. Reddy’s acquires a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications (ANDAs) in the US, including >30 generics injectable The focus of the acquisition is to enhance Dr. Reddy’s injectable portfolio in the US and globally Dr. Reddy’s will launch the products within the next one to two years and according to […]Read More

M&A

Therapiva Private Acquires Dr. Reddy’s API Manufacturing Unit Jeedimetla, Hyderabad

Shots: Therapiva to get hold of its all stocks including its related fixed assets, current assets, current liabilities, and employees The division is in response to focus on forming manufacturing operations and optimizing its cost structures and strengthening Therapiva’s API portfolio Therapiva Private Ltd is a joint venture between Omnicare Drugs India Private Limited (subsidiary […]Read More